Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted heterocycles as Janus kinase inhibitors

Substituted heterocycles as Janus kinase inhibitors

US Patent 8513270 · Granted Aug 20, 2013

Estimated economic value: $57,146,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as 2023
Tricyclic heterocycles as BET protein inhibitors2022
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as 2022
Salts of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-12022
Tricyclic heterocycles as BET protein inhibitors2021
Process for preparing a composition comprising an enantiomeric excess of greater2021
Tricyclic heterocycles as BET protein inhibitors2021
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as 2020
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidines derivatives as JAK2020
Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-12020
Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-42019
Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-42019